Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
University of Washington
University of Southern California
Massachusetts General Hospital
University of Miami
Icahn School of Medicine at Mount Sinai
Thomas Jefferson University
City of Hope Medical Center
RWTH Aachen University
M.D. Anderson Cancer Center
Ottawa Hospital Research Institute
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Swiss Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Icahn School of Medicine at Mount Sinai
Hospital Israelita Albert Einstein
Northside Hospital, Inc.
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
University of California, San Francisco
OHSU Knight Cancer Institute
Copenhagen University Hospital at Herlev
Case Comprehensive Cancer Center
Hoag Memorial Hospital Presbyterian
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center